Transplantation Proceedings
Volume 33, Issue 3, Supplement 1 , Pages S2-S3, May 2001

General considerations of immunosuppressive therapies—efficacy versus toxicity

  • J.H Helderman

      Affiliations

    • Vanderbilt Transplant Center and The Nephrology Division, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    • Corresponding Author InformationAddress reprint requests to J. Harold Helderman, MD, Professor of Medicine, Microbiology & Immunology, Chief, Renal Transplant Medicine, Medical Director, Vanderbilt Transplant Center, Vanderbilt University Medical Center, S-3305 Medical Center North, Nashville, Tennessee 37232-2372

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0041-1345(01)02062-0

Transplantation Proceedings
Volume 33, Issue 3, Supplement 1 , Pages S2-S3, May 2001

Article Tools